| FH10347 |
58066-85-6 |
1-Hexadecylphosphorylcholine |
|
Treatment for leishmaniasis |
|
| XFA95889 |
147958-89-2 |
1-(3-Phenylprop-2-enoyl)piperidine-4-carboxylic acid |
|
|
|
| VJB14271 |
870142-71-5 |
1-(4-Pentyloxy-3-trifluoromethylphenyl)-3-(pyridine-3-carbonyl)thiourea |
|
|
|
| PHA28013 |
189280-13-5 |
1-(6-Amino-3,5-difluoropyridin-2-yl)-8-bromo-6-fluoro-7-[3-(methylamino)azetidin-1-yl]-4-oxoquinoline-3-carboxylic acid |
|
|
|
| BD162702 |
1095588-70-7 |
10, 11-Dehydrocurvularin |
|
|
|
| AD46892 |
1013937-16-0 |
11-Deoxyfusidic acid |
|
|
|
| AB144420 |
60873-68-9 |
14-Bromodaunorubicin HBr |
|
|
|
| AC19942 |
121250-06-4 |
14-Chloro daunorubicin |
|
|
|
| AD21900 |
197909-66-3 |
1,3''-Di-HABA kanamycin A |
|
|
|
| AD21901 |
927821-99-6 |
1,3-Di-HABA kanamycin A |
|
|
|
| DAA88639 |
3886-39-3 |
1,4-Dihydro-2,3-benzodithiine |
|
|
|
| AD21902 |
197909-67-4 |
1,6'-Di-HABA kanamycin A |
|
|
|
| AD03945 |
53910-25-1 |
2'-Deoxycoformycin |
|
|
|
| AA16585 |
89000-32-8 |
2'-O-Acetylspiramycin I |
|
|
|
| NC05645 |
143491-54-7 |
2',3'-Dideoxy-5-fluoro-3'-thiacytidine |
|
Nucleoside reverse transcriptase inhibitor (NRTI) |
|
| GYA77230 |
581772-30-7 |
2',5-Difluoro-2'-deoxycytidine |
|
|
|
| TXB38811 |
1193388-11-2 |
2-Chloro-N-[2-oxo-2-(pyrrolidin-1-yl)ethyl]acetamide |
|
|
|
| FM164967 |
2682-20-4 |
2-Methyl-4-isothiazolin-3-one - 96% |
|
Antimicrobial and preservative used in personal care products |
|
| FM152298 |
26172-54-3 |
2-Methyl-4-isothiazolin-3-one HCl |
|
Antimicrobial and preservative used in personal care products |
|
| W-107194 |
26172-54-3 |
2-Methyl-4-isothiazolin-3-one hydrochloride |
|
Antimicrobial and preservative used in personal care products |
|
| TEA72156 |
118721-56-5 |
2-(3-Bromophenyl)-1,3-thiazolidine-4-carboxylic acid |
|
|
|
| MJA40098 |
237400-98-5 |
2-[(1-Adamantylcarbonyl)amino]-3-methylbutanoic acid |
|
|
|
| JDA49964 |
84499-64-9 |
2-[(2-Amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-aminopropanoate |
|
|
|
| AN181380 |
156223-31-3 |
21-Norrapamycin |
|
|
|
| AD21128 |
79039-56-8 |
25-Desacetyl rifapentin |
|
|
|
| AD21127 |
16783-99-6 |
25-Desacetylrifampin |
|
|
|
| AD20830 |
100324-63-8 |
25-O-Deacetyl rifabutin |
|
|
|
| AH46894 |
|
26-Hydroxyfusidic acid |
|
|
|
| AO46895 |
1415035-94-7 |
26-Oxofusidic acid |
|
|
|
| YCA49360 |
73493-60-4 |
28-Demethyl-β-amyrone |
|
|
|
| DKA43135 |
253431-35-5 |
28-Epirapamycin |
|
|
|
| AD21440 |
2161-86-6 |
2,4-Diacetylphloroglucinol |
|
|
|
| AD21349 |
612069-28-0 |
3'-N-Desmethyl-3'-N-formyl azithromycin |
|
|
|
| AD21350 |
612069-31-5 |
3'-N-Desmethyl-3'-N-tosyl azithromycin |
|
|
|
| AD21416 |
765927-71-7 |
3'-N,N-Di(desmethyl)-3'-N-formyl azithromycin |
|
|
|
| AD21415 |
612069-27-9 |
3'-N,N-Di(desmethyl) azithromycin |
|
|
|
| AD46890 |
1309349-64-1 |
3’(6’)-Dehydroclindamycin phosphate |
|
|
|
| AP177459 |
1252187-41-9 |
3- Phenyl- N- [1- (phenylmethyl) - 4- piperidinyl] -tricyclo[3.3.1.13, 7] decane- 1- carboxamide |
|
Inhibitor of surface glycoprotein in Ebola virus |
|
| PBA60790 |
39607-90-4 |
3-Chloro-10,11-dihydro-5H-dibenzo[B,D]azepine |
|
|
|
| FD157459 |
66340-28-1
Free base |
3-Desacetylcefotaxime potassium |
|
|
|
| AF23561 |
13292-22-3 |
3-Formyl rifamycin |
|
|
|
| QCB68479 |
690684-79-8 |
3-(3-Isopropoxypropyl)-2-mercaptoquinazolin-4(3H)-one |
|
|
|
| QKB40986 |
890409-86-6 |
3-(Methylsulfonyl)-2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)butanoate |
|
|
|
| DNA02836 |
328028-36-0 |
3-[(3,5-Dimethylpiperidin-1-yl)sulfonyl]benzoic acid |
|
|
|
| JXC26603 |
1809266-03-2 |
4''-(p-Fluorobenzyl)tylosin A |
|
|
|
| AE16714 |
56390-08-0 |
4'-Epidaunorubicin hydrochloride |
|
|
|
| GMA30507 |
306305-07-7 |
4'-Ethynyl-2'-deoxyadenosine |
|
|
|
| AD20995 |
52744-22-6 |
4-Demethyl daunomycinone |
|
|
|
| PAA29793 |
14297-93-9 |
4-Epichlortetracycline |
|
|
|
| AE22723 |
101342-45-4 |
4-Epichlortetracycline hydrochloride |
|
Protein synthesis inhibitor; tetracycline class |
|